# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA464249 | X_4c | Activity | 0 | ALA2354178 | Active | Homo sapiens | |||||
2. | ALA464249 | X_4c | IC50 | = | 0.44 | uM | ALA2354177 | 6.36 | nM | |||
3. | ALA464249 | X_4c | Efficacy | = | 44 | % | ALA4821041 | % | Severe acute respiratory syndrome coronavirus 2 | |||
4. | ALA464249 | X_4c | IC50 | = | 380 | nM | ALA4821040 | 6.42 | nM | Severe acute respiratory syndrome coronavirus 2 | ||
5. | ALA464249 | X_4c | IC50 | = | 0.84 | uM | ALA4821036 | 6.08 | nM | |||
6. | ALA464249 | X_4c | solubility | = | 9.2 | ug ml-1 | ALA4821035 | ug.mL-1 | ||||
7. | ALA464249 | X_4c | permeability | = | 334.4 | 10^-6 cm/s | ALA4821034 | 10^-6 cm/s | ||||
8. | ALA464249 | X_4c | Stabilty | > | 30 | min | ALA4821033 | min | ||||
9. | ALA464249 | X_4c | IC50 | = | 3.74 | uM | ALA4821032 | 5.43 | nM | |||
10. | ALA464249 | X_4c | IC50 | = | 2.5 | uM | ALA4821031 | 5.60 | nM | |||
11. | ALA464249 | X_4c | Activity | = | 59 | % | ALA4821030 | % | Homo sapiens | |||
12. | ALA464249 | X_4c | Inhibition | = | 7.02 | % | ALA3436044 | % | Leishmania mexicana | |||
13. | ALA464249 | X_4c | Inhibition | = | 6.83 | % | ALA3436043 | % | Plasmodium falciparum | |||
14. | ALA464249 | X_4c | Inhibition | = | 7.76 | % | ALA3436042 | % | Homo sapiens | |||
15. | ALA464249 | X_4c | pIC50 | = | 6.16 | ALA954137 | 6.16 | nM | Homo sapiens | |||
16. | ALA464249 | X_4c | XC50 | = | 1.141 | uM | ALA1054503 | 5.94 | nM | Plasmodium falciparum | ||
17. | ALA464249 | X_4c | Inhibition | = | 6 | % | ALA1054502 | % | Plasmodium falciparum | |||
18. | ALA464249 | X_4c | Inhibition | = | 87 | % | ALA1054500 | % | Plasmodium falciparum | |||
19. | ALA464249 | X_4c | IFI | = | 35.63 | % | ALA1054505 | % | ||||
20. | ALA464249 | X_4c | Inhibition | = | 100 | % | ALA1054501 | % | Plasmodium falciparum |